Numerous in vivo tumor models have been developed for preclinical studies, but there is limited genetic diversity modeled in these systems, and they do not capture the full spectrum of genetic heterogeneity found in human NF1-MPNST. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.